Back to Results
First PageMeta Content
Microbicides / HIV/AIDS / Sexually transmitted diseases and infections / Clinical research / Design of experiments / Microbicides for sexually transmitted diseases / CAPRISA 004 / Clinical trial / Condom / Medicine / Health / Microbiology


EXECUTIVE SUMMARY ADHERENCE AND ITS MEASUREMENT IN MICROBICIDE CLINICAL TRIALS A Workshop Project of the Quick Working Group Jointly Sponsored by the Alliance for Microbicide Development and Family Health International 1
Add to Reading List

Document Date: 2009-11-12 16:03:46

Open Document

File Size: 100,12 KB

Share Result on Facebook

City

Washington / DC / /

Company

Quick Working Group / ITT / /

Continent

Africa / /

Country

United States / /

/

Event

FDA Phase / Person Communication and Meetings / /

IndustryTerm

behavioral assessment tools / clinic monitoring protocol / web cast / HIV prevention / participant adherence to product / study protocol / travel distances / study product / delivery systems / efficacious product / /

MedicalCondition

HIV / tuberculosis / /

MedicalTreatment

anti-retroviral therapy / Antiretroviral Therapy / Directly Observed Therapy / HAART / counseling / /

Organization

Population Council / FDA / Alliance for Microbicide Development and Family Health International / /

Person

Robert Pool / Christine Mauck / Alex Carballo-Diéguez / Doug Taylor / Jeff Murray / Barbara Mensch / Stephanie Tillman / Johanna Rankin / Ariane van der Straten / Sheena McCormack / Nancy Padian / Connie Celum / Jen Deese / Mark Weaver / Betsy Tolley / Anne Coletti / Barbara Friedland / Carol Golin / Barbra Richardson / Leila Mansoor / /

Position

EXECUTIVE SUMMARY This Executive / general information session and product introduction / /

Product

Truvada / Carraguard® / FHI Truvada™ PrEP / HSV-2 / Network / /

ProgrammingLanguage

DC / /

Technology

clinic monitoring protocol / study protocol / bar code / cell phones / Interactive voice response / drug development / /

SocialTag